{"id":133740,"date":"2022-09-07T09:08:23","date_gmt":"2022-09-07T13:08:23","guid":{"rendered":"https:\/\/44.250.171.167\/?p=133740"},"modified":"2022-10-06T05:00:27","modified_gmt":"2022-10-06T09:00:27","slug":"sms-pharmaceuticals-limited-q1-fy23-earnings-conference-call-insights","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/sms-pharmaceuticals-limited-q1-fy23-earnings-conference-call-insights\/","title":{"rendered":"SMS Pharmaceuticals Limited Q1 FY23 Earnings Conference Call Insights"},"content":{"rendered":"<p><iframe loading=\"lazy\" title=\"SMS Pharmaceuticals Limited Q1 2023 Earnings Call\" width=\"500\" height=\"375\" src=\"https:\/\/www.youtube.com\/embed\/G2_d7tTye3s?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/p>\n<p><strong>Key highlights from SMS Pharmaceuticals Limited (<a href=\"https:\/\/44.250.171.167\/symbol\/SMSPHARMA\/\">SMSPHARMA<\/a>) Q1 FY23 Earnings Concall<\/strong><\/p>\n<p><strong>Q&amp;A Highlights:<\/strong><\/p>\n<ul>\n<li>Atul Kothari from Progwell Securities asked about the products under pipeline with Chemo JV. Vamsi Krishna ED replied that the products already on the pipeline are almost developed. There are 8 products as part of JV and except 1-2 products all have been validated and is waiting for patent expiry for commercialization.<\/li>\n<\/ul>\n<ul>\n<li>Atul Kothari from Progwell Securities also enquired about the revenue generated as of now from the Chemo JV. Vamsi Krishna ED replied that the revenue contribution in the current financial year is about 11%.<\/li>\n<\/ul>\n<ul>\n<li>Atul Kothari from Progwell Securities asked about the ANDAs VKT has as of now and how many can be expected by end of FY26. Vamsi Krishna ED replied that currently the company has 6 ANDAs and by FY22, SMSPHARMA will be filing two more ANDAs.<\/li>\n<\/ul>\n<ul>\n<li>Priyanka Shah of KP Advisors enquired about the R&amp;D expense as a percentage of revenue for FY22 and outlook for FY23. Vamsi Krishna ED answered that for FY22 it\u2019s about 4% and for FY23 expectation is growth of about 20% of previous year\u2019s expenditure.<\/li>\n<\/ul>\n<ul>\n<li>Priyanka Shah of KP Advisors asked how many new products have been launched in FY22 for non-ARV products and FY23 expected launch. Vamsi Krishna ED replied that commercial launch was three products. Next year, the company is planning to add about 8-10 products to the portfolio.<\/li>\n<\/ul>\n<ul>\n<li>Ankush Mahajan with Axis Securities asked about the revenue of top five products and revenue contribution for ibuprofen. Vamsi Krishna ED said that yearly antiretroviral typically contribute around 35% revenue. Antiretroviral, there\u2019s only one product, Tenofovir, which contributes to 35% of revenue. And ibuprofen contribution is less than 10% and expectation is about 35% growth in future.<\/li>\n<\/ul>\n<ul>\n<li>Meenal from CJ Shah and Company asked about the future expectation of pricing. Vamsi Krishna ED replied that IB prices have gone back to pre-2017-18 time period. The expectation is it won\u2019t go down any further.<\/li>\n<\/ul>\n<ul>\n<li>Nishita Shah of Raga Securities enquired if the company expects to turn EBITDA positive by end of 2Q23 and PAT positive by end of FY23. Vamsi Krishna ED said the company has set that target and is positive about the hope of achieving it.<\/li>\n<\/ul>\n<ul>\n<li>Viraj Parekh of JMP Capital asked about the pricing scenario pertaining to the API in 1Q23 vs. 4Q22. Vamsi Krishna ED clarified that it\u2019s not depreciated too much; it\u2019s about 5% here and there but not more than that.<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Key highlights from SMS Pharmaceuticals Limited (SMSPHARMA) Q1 FY23 Earnings Concall Q&amp;A Highlights: Atul Kothari from Progwell Securities asked about the products under pipeline with Chemo JV. Vamsi Krishna ED replied that the products already on the pipeline are almost developed. There are 8 products as part of JV and except 1-2 products all have [&hellip;]<\/p>\n","protected":false},"author":1767,"featured_media":125416,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"SMS Pharmaceuticals Limited Q1 FY23 Earnings Conference Call Insights #SMSPHARMA #Q1 #FY23  #Earnings","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[9825,392,5747],"tags":[1115],"class_list":["post-133740","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-earnings-call-highlights","category-earnings","category-healthcare-stocks","tag-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":130651,"url":"https:\/\/alphastreet.com\/india\/sms-pharmaceuticals-ltd-q4-fy22-earnings-conference-call-insights\/","url_meta":{"origin":133740,"position":0},"title":"SMS Pharmaceuticals Ltd Q4 FY22 Earnings Conference Call Insights","author":"Praveen","date":"June 15, 2022","format":false,"excerpt":"Key highlights from SMS Pharmaceuticals Ltd (SMSPHARMA) Q4 FY22 Earnings Concall Management Update: SMSPHARMA said its near-term focus remains on scaling up production for ibuprofen along with expanding the customer base for ibuprofen. Q&A Highlights: Akash Mehta of Capaz Investments asked about revenue contribution declining sharply from the ARV segment\u2026","rel":"","context":"In &quot;Concall Highlights&quot;","block_context":{"text":"Concall Highlights","link":"https:\/\/alphastreet.com\/india\/category\/earnings-call-highlights\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":136188,"url":"https:\/\/alphastreet.com\/india\/sms-pharmaceuticals-limited-smspharma-q2-fy23-earnings-concall-transcript\/","url_meta":{"origin":133740,"position":1},"title":"SMS Pharmaceuticals Limited (SMSPHARMA) Q2 FY23 Earnings Concall Transcript","author":"IRS_INDIA","date":"August 18, 2022","format":false,"excerpt":"SMS Pharmaceuticals Limited (NSE:SMSPHARMA) Q2 FY23 Earnings Concall Aug. 18, 2022 Corporate Participants: P. Vamsi Krishna -- Executed Director LakshminarayanaTammineedi -- Chief Financial Officer Analysts: Atul Kothari -- Progwell Securities -- Analyst P.D. Gupta -- Investors Forum -- Analyst Priyanka Shah -- KP Advisors -- Analyst Ankush Mahajan -- Axis\u2026","rel":"","context":"In &quot;Earnings Call Transcripts&quot;","block_context":{"text":"Earnings Call Transcripts","link":"https:\/\/alphastreet.com\/india\/category\/transcripts\/"},"img":{"alt_text":"stock earnings conference call transcript","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/02\/EarningsTranscript.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/02\/EarningsTranscript.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/02\/EarningsTranscript.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":130880,"url":"https:\/\/alphastreet.com\/india\/accuracy-shipping-ltd-q4-fy22-earnings-conference-call-insights\/","url_meta":{"origin":133740,"position":2},"title":"Accuracy Shipping Ltd Q4 FY22 Earnings Conference Call Insights","author":"Praveen","date":"June 29, 2022","format":false,"excerpt":"https:\/\/youtu.be\/p7b1aVNbuxM Key highlights from Accuracy Shipping Ltd (ACCURACY) Q4 FY22 Earnings Concall Q&A Highlights: Dipti Kothari from Kothari Securities enquired about the sharp increase in revenue YoY, while volume growth being only 14%. Vinay Tripathi MD said that the topline increased due to the freight rates increasing. Dipti Kothari from\u2026","rel":"","context":"In &quot;Concall Highlights&quot;","block_context":{"text":"Concall Highlights","link":"https:\/\/alphastreet.com\/india\/category\/earnings-call-highlights\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":142315,"url":"https:\/\/alphastreet.com\/india\/sms-pharmaceuticals-ltd-smspharma-q3-fy23-earnings-concall-transcript\/","url_meta":{"origin":133740,"position":3},"title":"SMS Pharmaceuticals Ltd (SMSPHARMA) Q3 FY23 Earnings Concall Transcript","author":"IRS_INDIA","date":"February 21, 2023","format":false,"excerpt":"SMS Pharmaceuticals Ltd (NSE:SMSPHARMA) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Vamsi Krishna Potluri\u00a0--\u00a0Executive Director Unidentified Speaker\u00a0-- Analysts: Viraj Shah\u00a0--\u00a0Shah Investments -- Analyst Aditi Sawant\u00a0--\u00a0ADM Advisors -- Analyst Dipti Kothari\u00a0--\u00a0Kothari Securities -- Analyst Mahesh Vyas\u00a0--\u00a0UTI Mutual Fund -- Analyst Unidentified Participant\u00a0--\u00a0-- Analyst Parth Vasani\u00a0--\u00a0KK Advisors -- Analyst\u2026","rel":"","context":"In &quot;Earnings Call Transcripts&quot;","block_context":{"text":"Earnings Call Transcripts","link":"https:\/\/alphastreet.com\/india\/category\/transcripts\/"},"img":{"alt_text":"Earnings Conference Call Transcript","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/09\/Transcript-thumbnail-e1657213425955.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/09\/Transcript-thumbnail-e1657213425955.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/09\/Transcript-thumbnail-e1657213425955.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":130911,"url":"https:\/\/alphastreet.com\/india\/kamdhenu-limited-q4-fy22-earnings-conference-call-insights\/","url_meta":{"origin":133740,"position":4},"title":"Kamdhenu Limited Q4 FY22 Earnings Conference Call Insights","author":"Praveen","date":"June 30, 2022","format":false,"excerpt":"Key highlights from Kamdhenu Limited (KAMDHENU) Q4 FY22 Earnings Concall Q&A Highlights: Ashray Jain of Jain Capital enquired about the current utilization levels and the utilization last quarter. Satish Agarwal MD replied that there was an impact of third wave on the business. The current utilization of paint is around\u2026","rel":"","context":"In &quot;Concall Highlights&quot;","block_context":{"text":"Concall Highlights","link":"https:\/\/alphastreet.com\/india\/category\/earnings-call-highlights\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":118169,"url":"https:\/\/alphastreet.com\/india\/hpl-electric-power-limited-hpl-q3-fy21-earnings-concall-transcript\/","url_meta":{"origin":133740,"position":5},"title":"HPL Electric &#038; Power Limited (HPL) Q3 FY21 Earnings Concall Transcript","author":"Sahil Anand","date":"January 18, 2021","format":false,"excerpt":"HPL Electric & Power Limited (NSE:HPL) Q3 FY21 earnings concall dated Call Jan. 18, 2021. Corporate Participants: Gautam Seth -- Joint Managing Director Analysts: Nandish Shah -- Moneycontrol Research -- Analyst Harshit Kapadia -- Elara Securities Private Limited -- Analyst Pankaj Bobade -- Axis Securities -- Analyst Atul Kothari --\u2026","rel":"","context":"In &quot;Earnings Call Transcripts&quot;","block_context":{"text":"Earnings Call Transcripts","link":"https:\/\/alphastreet.com\/india\/category\/transcripts\/"},"img":{"alt_text":"stock earnings conference call transcript","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/02\/EarningsTranscript.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/02\/EarningsTranscript.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/02\/EarningsTranscript.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/133740","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1767"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=133740"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/133740\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/125416"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=133740"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=133740"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=133740"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}